Showing results (101-110 of 995) with videos related to
Sort By:
Pageof 100
Biochemical Society Transactions|May 8, 2020
Systems approach to rational combination therapy: PARP inhibitorsChaoyang Sun, Yong Fang, Marilyne Labrie, et al.Cancer Informatics|November 7, 2014
A comprehensive comparison of normalization methods for loading control and variance stabilization of reverse-phase protein array dataWenbin Liu, Zhenlin Ju, Yiling Lu, et al.Biochimica Et Biophysica Acta|May 27, 2008
Sharpening the edges of understanding the structure/function of the LPA1 receptor: expression in cancer and mechanisms of regulationMandi M Murph, Giang H Nguyen, Harish Radhakrishna, et al.Autophagy|June 7, 2014
A curated census of autophagy-modulating proteins and small molecules: candidate targets for cancer therapyPhilip L Lorenzi, Sofie Claerhout, Gordon B Mills, et al.Molecular & Cellular Proteomics : MCP|May 3, 2018
Credentialing Individual Samples for Proteogenomic AnalysisWei Zhao, Jun Li, Rehan Akbani, et al.Nature Reviews. Clinical Oncology|October 26, 2018
State-of-the-art strategies for targeting the DNA damage response in cancerPatrick G Pilié, Chad Tang, Gordon B Mills, et al.Current Drug Targets|September 15, 2012
Proteomic classification of breast cancerDalia Kamel, Bernadette Brady, Adel Tabchy, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 22, 2010
Future of personalized medicine in oncology: a systems biology approachAna Maria Gonzalez-Angulo, Bryan T J Hennessy, Gordon B MillsMolecular Oncology|December 17, 2008
Lysophosphatidic acid (LPA)-induced vasodilator-stimulated phosphoprotein mediates lamellipodia formation to initiate motility in PC-3 prostate cancer cellsYutaka Hasegawa, Mandi Murph, Shuangxing Yu, et al.Trends in Molecular Medicine|June 3, 2026
Engaging the ZBP1 axis: from nucleic acid stress to antitumor immunityZhiqi Liao, Linghui Wang, Gordon B Mills, et al.Pageof 100